{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:25:14Z","timestamp":1782321914856,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["JDYY92018014"],"award-info":[{"award-number":["JDYY92018014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81503168"],"award-info":[{"award-number":["81503168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81803608"],"award-info":[{"award-number":["81803608"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cbi.2018.11.008","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T12:14:46Z","timestamp":1542370486000},"page":"130-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Omeprazole protects against cisplatin-induced nephrotoxicity by alleviating oxidative stress, inflammation, and transporter-mediated cisplatin accumulation in rats and HK-2\u202fcells"],"prefix":"10.1016","volume":"297","author":[{"given":"Huan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2018.11.008_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/hon.2335","article-title":"Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: a focus on cytochrome P450, transporters, and acid suppression therapy","volume":"35","author":"Gay","year":"2017","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.cbi.2018.11.008_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.taap.2013.12.015","article-title":"Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp","volume":"275","author":"Li","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2018.11.008_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cbi.2016.09.008","article-title":"Tangeretin attenuates cisplatin-induced renal injury in rats: impact on the inflammatory cascade and oxidative perturbations","volume":"258","author":"Arab","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2018.11.008_bib4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2353\/ajpath.2010.090610","article-title":"Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions","volume":"176","author":"Ciarimboli","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cbi.2018.11.008_bib5","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1572-0241.2007.01106.x","article-title":"The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use","volume":"102","author":"Targownik","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.cbi.2018.11.008_bib6","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1021\/mp400403s","article-title":"Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug\u2013drug interaction potential for molecular targeted agents in clinical development","volume":"10","author":"Smelick","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2018.11.008_bib7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00280-017-3296-7","article-title":"Co-administration of proton pump inhibitors ameliorates nephrotoxicity in patients receiving chemotherapy with cisplatin and fluorouracil: a retrospective cohort study","volume":"79","author":"Ikemura","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cbi.2018.11.008_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136451","article-title":"Substrate-dependent inhibition of the human organic cation transporter OCT2: a comparison of metformin with experimental substrates","volume":"10","author":"Hacker","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2018.11.008_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022163","article-title":"Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)","volume":"6","author":"Nies","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2018.11.008_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12967-015-0614-x","article-title":"Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis","volume":"13","author":"Ghebremariam","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cbi.2018.11.008_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2012.03.152","article-title":"Proton pump inhibitors suppress iNOS-dependent DNA damage in Barrett's esophagus by increasing Mn-SOD expression","volume":"421","author":"Thanan","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2018.11.008_bib12","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/jcb.24122","article-title":"Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases\/mTOR\/HIF-1\u03b1\/P-gp and MRP1 signaling pathway in vitro and in vivo","volume":"113","author":"Chen","year":"2012","journal-title":"J. Cell. Biochem. Suppl."},{"key":"10.1016\/j.cbi.2018.11.008_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10495-014-1044-6","article-title":"A novel oxaliplatin derivative, Ht-2, triggers mitochondrion-dependent apoptosis in human colon cancer cells","volume":"20","author":"Xing","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.cbi.2018.11.008_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.fct.2016.11.004","article-title":"Carvacrol attenuates acute kidney injury induced by cisplatin through suppression of ERK and PI3K\/Akt activation","volume":"98","author":"Poto\u010dnjak","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.cbi.2018.11.008_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188797","article-title":"Activation of the cholinergic anti-inflammatory pathway by GTS-21 attenuates cisplatin-induced acute kidney injury in mice","volume":"12","author":"Chatterjee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2018.11.008_bib16","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjc.6600884","article-title":"Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients","volume":"88","author":"de Jongh","year":"2003","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.cbi.2018.11.008_bib17","first-page":"547","article-title":"Membrane transporters as mediators of cisplatin side-effects","volume":"34","author":"Ciarimboli","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cbi.2018.11.008_bib18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.wneu.2017.04.136","article-title":"The protective effect of omeprazole against traumatic brain injury: an experimental study","volume":"104","author":"\u00d6zay","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.cbi.2018.11.008_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.taap.2017.04.013","article-title":"Targeting Oct2 and P53: formononetin prevents cisplatin-induced acute kidney injury","volume":"326","author":"Huang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2018.11.008_bib20","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1039\/C6FO00188B","article-title":"Antioxidant and anti-inflammatory potential of pomegranate rind extract to ameliorate cisplatin-induced acute kidney injury","volume":"7","author":"Karwasra","year":"2016","journal-title":"Food & Function."},{"key":"10.1016\/j.cbi.2018.11.008_bib21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00280-008-0711-0","article-title":"Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European society of clinical pharmacy special interest group on cancer care","volume":"61","author":"Launayvacher","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cbi.2018.11.008_bib22","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbagen.2013.12.007","article-title":"Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing acute kidney injury","volume":"1840","author":"Kodama","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2018.11.008_bib23","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0002-9440(10)61234-5","article-title":"Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2","volume":"167","author":"Ciarimboli","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cbi.2018.11.008_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40265-017-0729-x","article-title":"Clinical implications of P-glycoprotein modulation in drug\u2013drug interactions","volume":"77","author":"Lund","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.cbi.2018.11.008_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/molecules23020349","article-title":"Effects of phytochemical P-glycoprotein modulators on the pharmacokinetics and tissue distribution of doxorubicin in mice","volume":"23","author":"Kim","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2018.11.008_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tox.2018.05.002","article-title":"Transporter-dependent cytotoxicity of antiviral drugs in primary cultures of human proximal tubular cells","volume":"404\u2013405","author":"Lash","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2018.11.008_bib27","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1158\/1078-0432.CCR-14-0319","article-title":"Cisplatin-induced renal injury is independently mediated by OCT2 and p53","volume":"20","author":"Sprowl","year":"2014","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.cbi.2018.11.008_bib28","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1158\/1078-0432.CCR-10-0949","article-title":"Influence of Oct1\/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase","volume":"16","author":"Franke","year":"2010","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.cbi.2018.11.008_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fphar.2015.00085","article-title":"Role of transporters in the distribution of platinum-based drugs","volume":"6","author":"Harrach","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2018.11.008_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136451","article-title":"Substrate-dependent inhibition of the human organic cation transporter OCT2: a comparison of metformin with experimental substrates","volume":"10","author":"Hacker","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2018.11.008_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022163","article-title":"Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs)","volume":"6","author":"Nies","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2018.11.008_bib32","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00383-008-2229-2","article-title":"The proton pump inhibitor inhibits cell growth and induces apoptosis in human hepatoblastoma","volume":"24","author":"Morimura","year":"2008","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.cbi.2018.11.008_bib33","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/bjc.1996.254","article-title":"The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects","volume":"73","author":"Yamagata","year":"1996","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.cbi.2018.11.008_bib34","first-page":"8687","article-title":"Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells","volume":"10","author":"Del Pino","year":"2004","journal-title":"Clin. Canc. Res. Off. J Am Assoc. Canc Res."},{"key":"10.1016\/j.cbi.2018.11.008_bib35","series-title":"How to Overcome Cisplatin Resistance through Proton Pump Inhibitors","author":"Milito","year":"2009"},{"key":"10.1016\/j.cbi.2018.11.008_bib36","first-page":"595","article-title":"Proton pump inhibition enhances the cytotoxicity of paclitaxel in cervical cancer","volume":"49","author":"Song","year":"2017","journal-title":"Canc. Res. Treat. Off. J. Kor. Canc. Assoc."},{"key":"10.1016\/j.cbi.2018.11.008_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.intimp.2013.07.021","article-title":"Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway","volume":"17","author":"Huang","year":"2013","journal-title":"Int. Immunopharm."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718307701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718307701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:51:19Z","timestamp":1757857879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279718307701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":37,"alternative-id":["S0009279718307701"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2018.11.008","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omeprazole protects against cisplatin-induced nephrotoxicity by alleviating oxidative stress, inflammation, and transporter-mediated cisplatin accumulation in rats and HK-2\u202fcells","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2018.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}